Skip to content
Recall Observatory FDA recall evidence

Drug product

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

D-0028-2026

October 08, 2025

Class II

Product summary

Firm
ASTRAZENECA PHARMACEUTICALS
Event
Event 97760
Status
Ongoing
Classification
Class II
Quantity
916 pre-filled syringes
Official record key
drug-enforcement:D-0028-2026

Official wording

Reason: Lack of Assurance of Sterility:

Code information: Lot YJ0152, Expiry: 01/31/2028.

Distribution pattern: Nationwide in the U.S

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility